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Abstract
Background: Recent experimental approaches have unraveled essential migratory and functional differences of 
monocyte subpopulations in mice. In order to possibly translate these findings into human physiology and 
pathophysiology, human monocyte subsets need to be carefully revisited in health and disease. In analogy to murine 
studies, we hypothesized that human monocyte subsets dynamically change during ageing, potentially influencing 
their functionality and contributing to immunosenescence.
Results: Circulating monocyte subsets, surface marker and chemokine receptor expression were analyzed in 181 
healthy volunteers (median age 42, range 18-88). Unlike the unaffected total leukocyte or total monocyte counts, non-
classical CD14+CD16+ monocytes significantly increased with age, but displayed reduced HLA-DR and CX3CR1 surface 
expression in the elderly. Classical CD14++CD16- monocyte counts did not vary dependent on age. Serum MCP-1 
(CCL2), but not MIP1α (CCL3), MIP1β (CCL4) or fractalkine (CX3CL1) concentrations increased with age. Monocyte-
derived macrophages from old or young individuals did not differ with respect to cytokine release in vitro at steady 
state or upon LPS stimulation.
Conclusions: Our study demonstrates dynamic changes of circulating monocytes during ageing in humans. The 
expansion of the non-classical CD14+CD16+ subtype, alterations of surface protein and chemokine receptor expression 
as well as circulating monocyte-related chemokines possibly contribute to the preserved functionality of the 
monocyte pool throughout adulthood.
Background
Monocytes represent about 5-10% of peripheral blood
leukocytes in humans and mice. They originate from a
myeloid precursor in the bone marrow, circulate in the
blood, bone marrow and spleen, and then enter tissues
[1,2]. Monocytes are established circulating precursors
for tissue macrophages and dendritic cells (DCs). Migra-
tion of monocytes into tissues and differentiation into
macrophages or DCs is believed to be largely determined
by the inflammatory milieu, i.e. adhesion molecules,
chemokines and pathogen-associated pattern-recogni-
tion receptors [1]. The identification of different mono-
cyte subsets in mice [3] has prompted intensive research
over the last years to understand the true contribution of
monocyte subpopulations to the macrophage and tissue
DC pool in inflammatory disorders, but also in steady
state [1].
Heterogeneity among human monocytes was recog-
nized about thirty years ago [4,5], and several markers
like CD64 [6] or CD16 [7] have been suggested for differ-
entiating subpopulations of monocytes. The differential
expression of CD14 (part of the receptor for lipopolysac-
charide) and CD16 (also known as FcγRIII) are com-
monly used to define two major subsets in peripheral
blood: 'classical' CD14++CD16- monocytes, typically rep-
resenting up to 95% of the monocytes in a healthy indi-
vidual, and the 'non-classical' CD14+CD16+ cells
comprising the remaining fraction of monocytes [7].
These subsets differ in many respects, including adhesion
molecule and chemokine receptor (CCR) expression.
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Page 2 of 11CD14++CD16- monocytes express CCR2, CD62L (L-
Selectin) and FCγRI (CD64), whereas CD14+CD16+
monocytes lack CCR2, and have higher levels of MHC-II
and FCγRII (CD32). Both subsets express the receptor for
fractalkine, CX3CR1, but CD14+CD16+ monocytes char-
acteristically express higher levels [2,8]. Based on similar
adhesion molecule and chemokine receptor as well as
similar gene expression profiles, murine Gr1hi (Ly6Chi)
monocytes are considered counterparts of human
CD14++CD16- monocytes, and murine Gr1lo (Ly6Clo)
cells may represent the subpopulation comparable to
human CD14+CD16+ monocytes [8].
Intensive research efforts have unraveled important
functional characteristics of both monocyte subsets in
mice. While the Gr1hi monocytes are rapidly recruited to
sites of inflammation, such as in atherosclerosis, peritoni-
tis or after organ damage into the injured liver [9-12],
Gr1lo monocytes appear to have a more patrolling behav-
ior at the endothelium [13]. Consequently, Gr1hi mono-
cytes were found to give rise to pro-inflammatory
macrophages and TNF-producing DCs in inflamed tissue
[1,9,10,14], while Gr1lo monocytes have been proposed as
precursors for alternatively activated macrophages, pos-
sibly fulfilling functions in tissue repair and resident mac-
rophage/DC turnover [1,13,15]. All these studies have
raised the question how this knowledge can be translated
into understanding physiology and pathophysiology of
monocyte subsets in humans. We therefore aimed at
characterizing peripheral blood monocyte subsets in
healthy volunteers based on frequency, phenotype,
chemokine and chemokine receptor expression and func-
tionality assays ex vivo. Data from mice [2] and humans
[16] indicated that monocyte subsets considerably
change with age. Here, we show that the 'non-classical'
CD14+CD16+ monocytes specifically increase with age in
healthy volunteers, that monocyte-related chemokines
and chemokine receptors are regulated within individuals
of different ages and that the peripheral monocyte popu-
lation preserves its cytokine-secreting function during
ageing in adults.
Methods
Study participants
Healthy volunteers were recruited from the blood trans-
fusion institute and from the staff or former staff of the
Department of Medicine III of the University Hospital
Aachen, Germany (Table 1). The study protocol was
approved by the local ethics committee (ethics committee
of University Hospital Aachen, RWTH Aachen), and
written informed consent was obtained from each partic-
ipant. A brief medical history was performed to exclude
possible diseases. Besides the experimental analyses from
peripheral blood, all participants were routinely tested for
an automated blood count and differential blood count,
normal alanine aminotransferase activity and normal C-
reactive protein at the Institute for Clinical Chemistry of
the University Hospital Aachen, Germany. Using these
efforts, all participants, including the persons above 65
years of age, could be considered "healthy" based on
admission criteria of the extensively validated 'senieur
protocol' [17,18]. However, it is important that athero-
sclerosis cannot be ruled out following these criteria.
Isolation of PBMC and flow cytometry
Fresh blood samples were collected by venipuncture in
the morning in EDTA separator tubes and promptly
applied to PBMC isolation by Ficoll Density Gradient,
using LSM 1077 Lymphocyte Separation Medium (PAA,
Pasching, Austria) and centrifugation at 2200 rpm for 20
minutes at 20°C. The intermediate layer consisting of
peripheral blood mononuclear cells (PBMC) was washed
twice in HANKS's medium (PAA) containing 0.1% BSA
and 0.5 mM EDTA and twice with DMEM Buffer (PAA)
containing 2 mM EDTA and 0.5% BSA [8,19]. After
blocking of nonspecific antibody binding, the following
monoclonal antibodies and appropriate isotype controls
were used for flow cytometry: CD14, CD16, CD56, HLA-
DR, CD3, CD4, CD8, CD56, and CD19 (all BD); CCR2
(R&D Systems); CX3CR1 (MBL International, Woburn,
MA). Flow cytometric analysis was performed on a FACS
Canto-II (BD). The acquired data were analysed by
FlowJo software (TreeStar, Ashland, OR). Numbers of cir-
culating cells were assessed by the percentage of the
respective cell subset multiplied by the respective subset
of absolute cell count obtained from routine blood count.
Cell surface marker expression was quantified by deter-
mining median fluorescence intensity minus the respec-
tive isotype control from an otherwise fully stained
sample (MFI-FMO). Due to technical reasons, HLA-DR,
CCR2 and CX3CR1 stainings have only been performed
on 130/181 and 62/181 consecutively included subjects,
respectively.
Chemokine and cytokine detection
The release of chemokines/cytokines in human serum or
in culture medium supernatant was measured using
FlowCytomix (Bender Medsystems, Austria, Vienna) in
collaboration with the company, according to manufac-
turers' instructions. The system of cytokine detection is
based on antibody-coupled micro-bead populations of
which each specifically binds to a certain cytokine. The
antibody-coupled microspheres serve as a solid phase in
this sandwich immunoassay methodology, and multiple
sphere populations can be distinguished on a flowcytom-
eter and each population is coated with a different anti-
body. Measurements were performed in duplicates at 50
μL sample volume. Standards and samples were distrib-
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Page 3 of 11uted in 96-well plates. Mixture of coated beads and detec-
tion beads was added and incubated for one hour. After
washing twice Streptavidin-PE was added and incubated
for one hour. After washing twice the measurements were
done using a flowcytometer and analyzed by FlowCyto-
mixPro software (Bender) [19]. Serum concentrations of
Fractalkine were assessed by Cytometric Bead Assay (BD,
Heidelberg, Germany) according to manufacturer's
instructions [9].
Purification of monocytes, generation of monocyte-
derived macrophages and in-vitro stimulation
For isolation of peripheral monocytes blood was freshly
drawn from healthy volunteers in fully heparinised
syringes and, after diluting with PBS at a ratio of 1:1,
directly subjected to Ficoll isolation using LSM 1077
Lymphocyte Separation Medium (PAA, Pasching, Aus-
tria) and centrifugation at 1600 rpm for 40 minutes at
room temperature. PBMC were washed using PBS until
the supernatant was clear. 1 × 106 cells/ml were resolved
in 4 ml 1640 RPMI (Invitrogen) containing 1% penicillin-
streptomycin (PAA) and 1.5% heat inactivated autologous
serum and allowed to adhere for 35 min in Petri dishes
(Greiner Bio-one, Frickenhausen, Germany) at 37°C and
5% CO2. Non-adherent cells were discarded and the
adherent cell layer was washed five times with 37°C warm
1640 RPMI solution. The cells were then resolved in 2 ml
RPMI (5% heat inactivated autologous serum, 1% Penicil-
lin-Streptomycin). After 24 h in culture, cells were either
stimulated with 1 μg/mL LPS (Sigma-Adrich, Hamburg,
Table 1: Characteristics of the study cohort and experimental measurements.
all volunteers age groups [years]
<30 30 - 50 >50
[n] 181 51 70 60
male/female [n] 105/76 28/23 42/28 35/25
age [years] 42 (18-88) 25 (18-29) 43 (30-50) 58 (51-88)
hemoglobin concentration [g/L] 139 (96-172) 144 (122-172) 138 (96-162) 138 (104-159)
platelet count [×109/L] 261 (150-509) 275 (184-424) 265 (193-509) 252 (150-370)
total leukocytes [×109/L] 5.9 (1.7-11.6) 5.9 (3.6-11.6) 6.1 (1.7-10.2) 5.8 (3.3-9.5)
total monocytes [×106/L] 450 (170-990) 424 (170-810) 462 (170-990) 461 (190-880)
CD14++CD16- monocytes [%] 7.05 (2.82-11.99) 6.69 (2.82-11.49) 7.14 (2.86-11.93) 7.26 (3.44-11.99)
CD14++CD16- monocytes [×106/L] 412.8 (155.1-903.0) 394.3 (155.1-776.5) 414.3 (165.7-902.9) 420.3 (165.2-902.9)
CD14+CD16+ monocytes [%] 0.54 (0.14-1.93) 0.42 (0.15-1.51) 0.59 (0.14-1.71) 0.69 (0.27-1.93)
CD14+CD16+ monocytes [×106/L] 33.7 (8.15-107.6) 24.3 (8.15-107.6) 35.7 (8.28-106.1) 37.8 (14.8-106.3)
serum MCP-1/CCL2 [pg/mL] 555 (61-1851) 450 (109-880) 573 (122-1851) 654 (61-1563)
serum MIP1α/CCL3 [pg/mL] 178 (14-10084) 470 (14-10084) 172 (14-10000) 123 (14-10000)
serum MIP1β/CCL4 [pg/mL] 32 (6-1107) 27 (10-1107) 33 (6-413) 32 (11-200)
serum fractalkine/CX3CL1 [pg/mL] 27.0 (0-80.5) 22.4 (0-62.6) 30.5 (0-68.7) 27.0 (0-80.5)
The median and range (in parenthesis) is given for quantitative parameters. % refers to % of leukocytes.
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for 24 hours, supernatants were collected and stored at -
80°C.
Statistics
Data are given as median, minimum, maximum, and
shown graphically by box-and-whiskers plots [20]. The
box-and-whiskers plots display a statistical summary of
the median (bold line), quartiles (boxes), range and
extreme values. The whiskers extend from the minimum
to the maximum value excluding outside (>1.5 times
upper/lower quartile, open circle) and "far out" (>3 time
upper/lower quartile, asterixes) values which are dis-
played separately. The degree of association between two
variables was assessed by the Spearman rank correlation
test. Comparisons of parameters between two different
groups were conducted with the Mann-Whitney-U-test.
Comparisons between three groups (e.g., volunteers of
different age classes) were done with the Kruskal-Wallis
analysis of variances (ANOVA), followed by Mann-Whit-
ney-U-tests for post hoc analysis. All tests were carried
out with SPSS (SPSS, Chicago, IL), and p-values < 0.05
were considered statistical significant.
For the in vitro experiments, bar graphs represent the
mean and the standard error of the mean (SEM). Statisti-
cal comparisons between groups were performed using
the Mann-Whitney-U-test with Prism 3.0 (GraphPad). P-
values < 0.05 were considered statistical significant.
Results
The non-classical CD14+CD16+ monocyte subset 
specifically increases with age in healthy adults
We studied circulating leukocyte subsets from 181
healthy volunteers at different ages by subjecting fresh
PBMC to immediate FACS analysis (Table 1). Within
healthy adults, total numbers of circulating white blood
cells, neutrophils or total monocytes did not change
dependent on the age of the volunteers (Fig. 1A-C).
Moreover, no differences were observed between male
and female volunteers (data not shown). Within the lym-
phocytes (Fig. 1D-E), a slight decrease in circulating T
cells, identified by positive staining for CD3 and negativ-
ity for CD56, was noted in persons above 50 years of age
that could be attributed to lower numbers of CD8+ T cells
(Fig. 1E). A similar observation was found for circulating
NK cells (CD56+CD3- cells) that were significantly
reduced in volunteers above 50 years (Fig. 1E).
Circulating monocytes were further subdivided by
FACS analysis into CD14++CD16- and CD14+CD16+ (also
called CD14dimCD16bright) monocytes according to the
expression of CD14 and CD16 on their surface (Fig. 2A).
Although the number of total monocytes did not differ,
we observed a clear correlation between the 'non-classi-
cal' CD14+CD16+ monocyte subset and age (r = 0.238, p =
0.001, Spearman rank correlation test). Both the absolute
numbers of the 'non-classical' CD14+CD16+ monocytes
as well as their relative contribution to the circulating
monocyte pool increased with the age of the study partic-
ipants (Fig. 2B). No difference was found between male
and female individuals (data not shown).
Age-dependent changes of monocytic chemokine receptor 
expression
We next aimed at identifying phenotypic differences
between monocyte subsets of young and old(er) adults.
We therefore analyzed the expression of the MHC-II
molecule HLA-DR that is considered as an activation
marker of monocytes and found at higher levels on
CD14+CD16+ monocytes [2,8]. Interestingly, the expres-
sion of HLA-DR was significantly lower on CD14+CD16+
monocytes of older volunteers, which was apparent by
analyzing the ratio of HLA-DR expression between
CD14++ and CD14+CD16+ monocytes as well as by
directly analyzing HLA-DR levels on each subset (Fig. 3A
and Additional file 1).
The chemokine receptors CCR2 and CX3CR1 are dif-
ferentially expressed on both monocyte subsets and have
been implicated in their migration and function [10].
While CD14++CD16- monocytes express high levels of
CCR2 and low levels of CX3CR1, CD14+CD16+ mono-
cytes express very low levels of CCR2 and high levels of
CX3CR1 (Fig. 3B). Interestingly, expression of CX3CR1
was downregulated on CD14+CD16+ monocytes in older
volunteers compared to young adults (Fig. 3C), but not
downregulated on CD14++CD16- monocytes. The 'classi-
cal' monocytes displayed some variation in CCR2 expres-
sion, with highest levels in volunteers at the age between
30 and 50 years (Fig. 3C). Collectively, these data indicate
that not only the absolute number of the 'non-classical'
CD14+CD16+ monocytes increase with age, but also their
phenotype changes dependent on age, resulting in lower
expression of activation markers and chemokine recep-
tors.
Serum MCP-1 concentrations, but not other monocyte-
related chemokine levels, increase with age
In various experimental animal models of inflammatory
disorders, the chemokine receptors CCR2, CCR1, CCR5
and CX3CR1 are involved at different stages of monocyte
subset migration [10,21]. Of note, MCP-1, the ligand for
CCR2, regulates Gr1hi/Ly6Chi 'classical' monocyte migra-
tion by promoting their exit from the bone marrow into
the circulation in mice [14,22]. In agreement with these
observations from mice, we found increased systemic
concentrations of MCP-1 in the serum of healthy volun-
teers dependent on their age (Fig. 4A-B). Moreover, the
body-mass index positively correlated with serum MCP-1
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MIP1α and MIP1β, both ligands of CCR1 and CCR5, or
fractalkine, the ligand for CX3CR1, were not associated
with the age of the volunteers (Fig. 4D-F).
Monocyte-derived macrophages remain functionally 
active in healthy aged volunteers
In order to assess possible alterations of the functionality
of monocytes dependent on the age, we tested the capac-
ity of monocyte-derived macrophages to produce cytok-
ines in vitro. An imbalanced cytokine production by
monocyte-derived macrophages had been reported in a
prior study of geriatric volunteers (with a mean age of 88
years) [16], but similar data for adults of different age
groups are lacking. Monocytes were isolated from n = 12
young (median age 24, range 21-28) and n = 10 old adults
(median age 60, range 35-88) and differentiated in vitro
into macrophages by overnight culture in medium sup-
plemented with autologous serum. We then assessed
spontaneous cytokine/chemokine production as well as
after stimulation with LPS. No morphological differences
were visible between monocyte-derived macrophages
from young or old volunteers (Fig. 5A). In line, constitu-
tive cytokine/chemokine production did not differ
dependent on the age (Fig. 5B). Monocyte-derived mac-
rophages secreted high amounts of the proinflammatory
cytokines TNFα, IL6, IL1β, of the antiinflammatory
cytokine IL10 and also the chemokines MCP-1, MIP1α
and MIP1β upon stimulation with LPS, while MIG was
not significantly induced by LPS. Again, cells derived
from old volunteers displayed a fully preserved functional
capacity to produce these cytokines/chemokines upon
LPS stimulation (Fig. 5B).
Discussion
Alterations in the numbers, phenotype and functionality
of monocyte subsets have recently gained remarkable
attention, because the identification of murine monocyte
Figure 1 Age-dependent changes of circulating leukocytes. Box plots display absolute numbers of circulating total leukocytes (A), neutrophils (B), 
monocytes (C), lymphocytes (D) and lymphocyte subsets (E) in 109/L for the different groups of young (<30 years, n = 51), middle-aged (30-50 years, 
n = 70) and old (>50 years, n = 60) healthy volunteers. The bold black line indicates the median per group, the box represents 50% of the values, and 
horizontal lines show minimum and maximum values of the calculated non-outlier values; open circles indicate outlier values. Significant differences 
(Kruskal-Wallis and U-test) are marked by *p < 0.05.
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Page 6 of 11subpopulations has revealed new insights into their criti-
cal functions for macrophage and dendritic cell homeo-
stasis as well as during inflammatory responses. For
instance, the appearance of monocyte subsets in periph-
eral murine blood is the result of several well regulated
processes at the level of bone marrow exit, half-life in
blood and release from the spleen that can serve as an
important reservoir [1,14,23]. Their differential recruit-
ment in steady state or to sites of inflammation involves a
cascade of contacts with endothelial proteins, adhesion
molecule expression and chemokine-chemokine receptor
interactions [10,13,24], and some of these mechanisms
are highly specific for each monocyte subset, resulting in
their selective or sequential accumulation and determin-
ing their function in health and disease [1,9,10,15,24]. It is
an ongoing challenge to establish which of these mecha-
nisms can be translated into human physiology and
pathophysiology.
We here conducted a study aiming at thoroughly char-
acterizing alterations of monocyte subpopulations in
healthy human volunteers at different ages. The effects of
ageing on adaptive and innate immune responses in
humans remain incompletely understood. The increased
susceptibility to infections and the reduced response to
vaccinations in old people have been linked to T- and B-
cell functions [25], but also changes in the innate immune
systems, including neutrophils, monocytes, mac-
rophages, natural killer and natural killer T (NKT) cells
and dendritic cells, have been reported to contribute to
the "immunosenescence" observed at old age [26]. Our
study demonstrates a significant shift from 'classical'
CD14++CD16- to 'non-classical' CD14+CD16+ monocytes
with increasing age in healthy adults. These results are
well in agreement with a prior smaller study that reported
a significant expansion of CD14+CD16+ monocytes in the
Figure 2 Age-dependent changes of circulating monocyte subsets. (A) Representative FACS plots display an increase of CD14+CD16+ monocytes 
(grey gate) in comparison to classical CD14++CD16- monocytes (black gate) among freshly isolated PBMC from old (right plot, 51 years-old male) versus 
young (left plot, 24 years-old female) volunteers. (B) Box plots display absolute numbers of circulating CD14++CD16- monocytes (left), CD14+CD16+ 
monocytes (middle) and the relative percentage of CD14+CD16+ from total monocytes (right) for the different groups of young (<30 years, n = 51), 
middle-aged (30-50 years, n = 70) and old (>50 years, n = 60) healthy volunteers. The bold black line indicates the median per group, the box repre-
sents 50% of the values, and horizontal lines show minimum and maximum values of the calculated non-outlier values; open circles indicate outlier 
values. Significant differences (Kruskal-Wallis and U-test) are marked by *p < 0.05, **p < 0.01 and ***p < 0.0015.
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Page 7 of 11elderly, although both studies are not directly compara-
bly, because the prior study compared very old (mean age
88 years) with young (mean age 30 years) subjects [16].
Moreover, the CD14+CD16+ monocytes undergo phe-
notypic changes during ageing, as they display reduced
levels of the activation molecule HLA-DR and of the key
chemokine receptor CX3CR1. Especially the latter finding
might be functionally relevant, because CX3CR1 has been
implicated to promote monocyte/macrophage survival in
some conditions like atherosclerosis [27]. Given experi-
Figure 3 Age-dependent changes of HLA-DR and chemokine receptor expression on monocyte subsets. (A) HLA-DR expression was analyzed 
by FACS on monocyte subsets (representative histogram of a 52-years old male is shown). Box plots demonstrate alterations of HLA-DR expression 
on both subsets using the ratio of HLA-DR between CD14+CD16+ and CD14++CD16- monocytes for the different groups of young (<30 years, n = 37), 
middle-aged (30-50 years, n = 50) and old (>50 years, n = 43) healthy volunteers. *p < 0.05. (B) Chemokine receptor expression was studied by FACS 
on both circulating monocyte subsets. Representative histograms (from a 65-years old male) display that CD14+CD16+ monocytes express higher lev-
els of CX3CR1, whereas CCR2 is primarily detected on classical CD14++CD16- monocytes. (C) Bar graphs depict changes in chemokine receptor expres-
sion (quantified as median fluorescence intensity minus "fluorescence minus one", MFI-FMO) for both monocyte subsets for the different groups of 
young (<30 years, n = 21), middle-aged (30-50 years, n = 22) and old (>50 years, n = 19) healthy volunteers. *p < 0.05.
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Page 8 of 11mental data from mice, reduced CX3CR1 expression on
non-classical monocytes in humans is likely to affect their
migration to inflammatory sites and to the spleen [10,28],
but could also reduce the half-life of monocyte-derived
tissue macrophages [29]. Therefore, increased numbers
of circulating CD14+CD16+ monocytes may not necessar-
ily mean enhanced availability and functionality in aged
persons.
At the level of circulating chemokines, we observed a
marked increase of serum MCP-1 (CCL2) concentrations
with age. Independent studies have reported increasing
MCP-1 concentrations in older volunteers previously and
speculated that this could be related to development of
(subclinical) atherosclerosis or an age-dependent shift
between T-helper cell dependent cytokine patterns (Th1/
Th2) [30,31]. In our cohort, we observed a correlation
between serum MCP-1 and the body mass index, possibly
indicating an association with obesity and adipose tissue-
derived macrophages or obesity-induced hepatic MCP-1
expression as important sources of circulating MCP-1
[32,33]. Interestingly, neither was CCR2 expression
downregulated on CD14++CD16- monocytes in response
to MCP-1 levels nor did serum concentrations of frac-
talkine (CX3CL1) or the CCR1/CCR5 ligands CCL3
(MIP1α) and CCL4 (MIP1β) change with age.
Surprisingly, our experiments further indicate that the
observed changes in the number and phenotype of circu-
lating monocyte subsets do not largely impact their over-
all functionality, at least not in the studied age-range of
healthy adults (mean age 41 years, 95%-interval 20-68
years). This is unexpected, because CD14+CD16+ mono-
cytes, which are significantly expanded in older volun-
teers, are generally believed to have a much higher
capacity to secrete proinflammatory cytokines [2]. We
recently confirmed these assumptions, as CD14+CD16+
monocytes derived from healthy volunteers produce sig-
Figure 4 Age-dependent changes of circulating monocyte-related chemokine levels. Box plots display serum concentrations of the chemok-
ines MCP-1 (A), MIP1α (D), MIP1β (E) and fractalkine (F) for the different groups of young (<30 years, n = 51), middle-aged (30-50 years, n = 70) and old 
(>50 years, n = 60) healthy volunteers. The bold black line indicates the median per group, the box represents 50% of the values, and horizontal lines 
show minimum and maximum values of the calculated non-outlier values; open circles indicate outlier values. Significant differences (Kruskal-Wallis 
and U-test) are marked by ***p < 0.0015. (B+C) MCP1 serum concentrations correlate with the age (r = 0.266, p = 0.001) and the body-mass index (BMI, 
r = 0.430, p = 0.013) in healthy volunteers (Spearman rank correlation test).
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Figure 5 Functional properties of monocyte-derived macrophages from young and old volunteers. Macrophages derived from freshly isolated 
PBMC from n = 12 volunteers aged <30 years (<30) and from n = 10 volunteers aged >30 years (>30) were cultured in medium containing autologous 
serum for 24 h and then stimulated with 1 μg/ml LPS for additional 24 h or left untreated. (A) Macrophages display an activated, round-shaped mor-
phology after LPS stimulation, but no overt morphological differences were detected between macrophages from young or old adults. (B) Bar graphs 
show mean cytokine and chemokine levels (in pg/mL) in the supernatant at day 2, error bars represent SEM.
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Page 10 of 11nificantly more TNF, IL6, MIP1α, MIP1β, IFNγ and MIG
upon culture without specific stimulation, while
CD14++CD16- monocytes readily release more MCP-1
and IL-10 in vitro [19].
In our study, the constitutive and inducible synthesis of
cytokines and chemokines was similar between total
monocytes cultured from young and old(er) adults,
although the fraction of the CD14+CD16+ subset was
expanded in the cells derived from older persons. Possi-
bly, the expansion of the 'non-classical' monocytes with
age might represent a physiological counter-regulatory
reaction, in order to preserve the overall functionality of
the monocyte pool throughout life-time. However, it is
important to note that our experimental setting did not
allow to differentiate the distinct contribution of each
subset to the overall cytokine release and that our in-vitro
results do not necessarily have to reflect the true behav-
iour of monocyte-derived cells in their respective
(inflamed or non-inflamed) in-vivo microenvironment.
Our results of a preserved cytokine secretion function
of monocyte-derived macrophages in older volunteers
confirm a report that compared macrophages only from
women [34], but are in contrast to prior studies [16,35].
However, these divergent studies analyzed cells from
remarkably older people than in our study, suggesting
that monocyte functionality may decrease during further
ageing. In elderly persons with a mean age 88 years,
monocyte-derived macrophages were reported to display
an imbalanced production of cytokines, with higher IL1β
and IL6 at steady state as well as lower IL1β and higher
IL6 and IL10 secretion upon stimulation [16]. Similarly,
higher TNF, IL1β and IL6 levels were reported in mac-
rophages from old (mean age 80 years) compared to
young (mean age 27 years) subjects [35].
Conclusions
Our study indicates that the circulating monocyte pool
dynamically changes during ageing in humans. The
expansion of the non-classical CD14+CD16+ subtype,
alterations of surface protein and chemokine receptor
expression as well as circulating monocyte-related
chemokines likely allow the preservation of functionality
for the monocyte pool throughout the majority of adult-
hood.
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